Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dose-Dependent Inhibition of Protein Glycosylation Reveals Crosstalk between Glycosylation and Phosphorylation in EGF Signaling Pathways. | Anal Chem | 2026 | 41843583 | PubTator, text mining | PubMed |
| Cofilin hyperphosphorylation triggers TDP-43 pathology in sporadic amyotrophic lateral sclerosis. | Brain | 2026 | 41804798 | PubTator, text mining | PubMed |
| Spinal motor neuron degeneration after brachial plexus avulsion: mechanisms and therapeutic targets. | Front Neurosci | 2026 | 41777735 | PubTator, text mining | PubMed |
| CeRNA plays a key role in the induction of cardiovascular diseases by environmental endocrine disruptor exposure. | Environ Health Prev Med | 2026 | 41765384 | PubTator, text mining | PubMed |
| Defining the Active Conformation of Typical Protein Kinase Domains from Substrate-Bound PDB Structures Enables Active-State AlphaFold2 Models for All 437 Human Catalytic Protein Kinases. | bioRxiv | 2026 | 41757035 | PubTator, text mining | PubMed |
| Maintaining Genome Integrity: Actin Polymerization Stabilizes Chromatin Bridges in Cytokinesis. | Int J Mol Sci | 2026 | 41752129 | PubTator, text mining | PubMed |
| Biomechanical Forces in Prostate Cancer: Current Insights and Future Directions. | Cancers (Basel) | 2026 | 41749861 | PubTator, text mining | PubMed |
| The Role of Actin-Binding Proteins in Breast Cancer Progression. | Breast Cancer (Dove Med Press) | 2026 | 41743193 | PubTator, text mining | PubMed |
| MRCKα represses GEF-H1 mediated RhoA activation to promote ovarian cancer spheroid growth and invasion. | bioRxiv | 2026 | 41726953 | PubTator, text mining | PubMed |
| Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer's Disease. | Pathophysiology | 2026 | 41718392 | PubTator, text mining | PubMed |
| Role and underlying mechanisms of miR‑200 family in breast cancer (Review). | Int J Oncol | 2026 | 41716019 | PubTator, text mining | PubMed |
| Sesquiterpenoids target IFIT family proteins and LIMK1: potential implications for the tumor microenvironment and macrophage infiltration. | BMC Cancer | 2026 | 41688967 | PubTator, text mining | PubMed |
| LIMK2 inactivation suppresses mechanical stimulation-induced dermal fibroblast differentiation and resistance to apoptosis. | Sci Rep | 2026 | 41644972 | PubTator, text mining | PubMed |
| Rho-associated kinase 1 (ROCK1) exerts distinct roles during the early infection versus replication phases of Minute Virus of Canines (MVC). | Microb Pathog | 2026 | 41644070 | PubTator, text mining | PubMed |
| Loss of Cathepsin K Impairs Collagen Biogenesis and Enhances Actin Polymerization in Trabecular Meshwork. | Invest Ophthalmol Vis Sci | 2026 | 41615370 | PubTator, text mining | PubMed |
| The Senescence-SASP Landscape in Colon Adenocarcinoma: Prognostic and Therapeutic Implications. | Curr Issues Mol Biol | 2026 | 41614944 | PubTator, text mining | PubMed |
| Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression. | Cancer Biol Ther | 2026 | 41606955 | PubTator, text mining | PubMed |
| RHOJ-induced chemotherapy resistance through epithelial-mesenchymal transition in drug-tolerant persister cells of head and neck cancer. | Transl Oncol | 2026 | 41548474 | PubTator, text mining | PubMed |
| RETRACTION: Diallyl Disulfide Downregulating RhoGDI2 Induces Differentiation and Inhibit Invasion Via the Rac1/Pak1/LIMK1 Pathway in Human Leukemia HL-60 Cells. | Environ Toxicol | 2026 | 41510596 | PubTator, text mining | PubMed |
| Microscale Thermophoresis for Thermodynamic Analysis: A Proof-of-Concept Study on LIMK Inhibitors. | J Mol Biol | 2026 | 41494592 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=2